Story perspectives

Goldman Sachs Names Top Investments Amid Market Volatility

2/15/2026

Summary

Story summary

Goldman Sachs identifies Nvidia, Teva, Philip Morris, S&P Global, and Apollo Global as compelling investments amid market volatility.
Goldman Sachs analyst Matt Dellatorre raises Teva's price target to $45 per share, citing a strong earnings trajectory.
Philip Morris is transforming into a more profitable business, with shares up nearly 18% this year.
S&P Global has declined 22% this year while remaining on track to achieve mid-to-high single-digit organic revenue growth.

1 of 1

Story summary

Goldman Sachs identifies Nvidia, Teva, Philip Morris, S&P Global, and Apollo Global as compelling investments amid market volatility.
Goldman Sachs analyst Matt Dellatorre raises Teva's price target to $45 per share, citing a strong earnings trajectory.
Philip Morris is transforming into a more profitable business, with shares up nearly 18% this year.
S&P Global has declined 22% this year while remaining on track to achieve mid-to-high single-digit organic revenue growth.